Molecular mechanisms of cisplatin resistance in ovarian cancer

Abstract excerpt

Ovarian cancer is one of the most common malignant tumors of the female reproductive system. The majority of patients with advanced ovarian cancer are mainly treated with cisplatin-based chemotherapy. As the most widely used first-line anti-neoplastic drug, cisplatin produces therapeutic effects through multiple mechanisms. However, during clinical treatment, cisplatin resistance has gradually emerged,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genomics, phytochemicals, and oxidative stress
• Share to Ovarian cancer diagnosis and treatment
• Share to PARP inhibition in cancer therapy